R Clift
- Hematology top 0.5%
- Hematopoietic Stem Cell Transplantation 31
- Acute Myeloid Leukemia Research 7
- Chronic Myeloid Leukemia Treatments 5
- Genetics top 2%
- Mesenchymal stem cell research 3
- Chronic Lymphocytic Leukemia Research 3
- Transplantation top 2%
- Oncology top 5%
- Neutropenia and Cancer Infections 7
- Polyomavirus and related diseases 6
- Immunology top 5%
-
- Hematological disorders and diagnostics 5
- Co-authors
- CD BucknerJack W. SingerF R AppelbaumRainer StorbK LillebyH. Joachim DeegJohn A. HansenS Rowley
- Cited by
- HematologyGeneticsTransplantation
- Journals
- Blood (14 papers)Journal of Clinical Oncology (6 papers)British Journal of Cancer (2 papers)
- Partner nations
- United StatesSouth AfricaUnited Kingdom
In The Last Decade
R Clift
43 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 95
- Hematology 1.9k
- Genetics 554
- Transplantation 130
- Oncology 870
- Immunology 649
Countries citing papers authored by R Clift
This map shows the geographic impact of R Clift's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Clift with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Clift more than expected).
Fields of papers citing papers by R Clift
This network shows the impact of papers produced by R Clift. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Clift. The network helps show where R Clift may publish in the future.
Co-authorship network
The 25 scholars most cited alongside R Clift, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 121 | |
| 2 | 1999 | 135 | |
| 3 | 1997 | 58 | |
| 4 | High-dose busulfan, melphalan, and thiotepa followed by autologous peripheral blood stem cell transplantation in patients with aggressive lymphoma or relapsed Hodgkin's disease. | 1997 | 22 |
| 5 | Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia. | 1996 | 78 |
| 6 | Busulfan, cyclophosphamide and fractionated total body irradiation for allogeneic marrow transplantation in advanced acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levels. | 1996 | 32 |
| 7 | 1995 | 71 | |
| 8 | 1994 | 9 | |
| 9 | 1993 | 43 | |
| 10 | 1993 | 2 | |
| 11 | 1992 | 45 | |
| 12 | 1989 | 26 | |
| 13 | 1988 | 6 | |
| 14 | 1983 | 2 | |
| 15 | 1983 | 15 | |
| 16 | 1976 | 7 | |
| 17 | 1964 | 7 | |
| 18 | 1963 | 11 | |
| 19 | 1961 | 49 | |
| 20 | 1961 | 16 |
About R Clift
R Clift is a scholar working on Hematology, Genetics and Oncology, having authored 43 papers that have together received 2.7k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (31 papers), Acute Myeloid Leukemia Research (7 papers), Neutropenia and Cancer Infections (7 papers), Polyomavirus and related diseases (6 papers), Chronic Myeloid Leukemia Treatments (5 papers), Hematological disorders and diagnostics (5 papers), Mesenchymal stem cell research (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). The work is most often cited by research in Hematology (1.9k citations), Genetics (554 citations) and Transplantation (130 citations). R Clift has collaborated with scholars based in United States, South Africa and United Kingdom. Frequent co-authors include CD Buckner, Jack W. Singer, F R Appelbaum, Rainer Storb, K Lilleby, H. Joachim Deeg, John A. Hansen, S Rowley, FR Appelbaum and Taner Demirer. Their work appears in journals such as Blood, Journal of Clinical Oncology, British Journal of Cancer, Transfusion and Leukemia Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.